| Financial Year |
March 31 2023 |
| Monetary Funds |
18,930,529,869.00 |
| Held-for-trading Financial Assets |
6,161,612,612.00 |
| Notes Receivable |
554,900,679.00 |
| Accounts Receivable |
8,244,648,262.00 |
| Advances to Suppliers |
3,268,052,629.00 |
| Other Receivables |
3,550,997,163.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
65,610,320.00 |
| Dividend Receivable |
-- |
| Inventories |
30,598,976,065.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
687,143,138.00 |
| Other Current Assets |
5,370,563,714.00 |
| Total Current Assets |
80,510,670,360.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,827,816,997.00 |
| Investment Properties |
448,937,980.00 |
| Fixed Assetes |
75,356,035,224.00 |
| Under-construction Projects |
24,394,875,346.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,782,357,182.00 |
| R&D expenses |
-- |
| Goodwill |
717,723,949.00 |
| Long-Term Deferred and Prepaid Expenses |
2,180,291,679.00 |
| Deferred Income Tax Assets |
1,706,023,235.00 |
| Other Non-Current Assets |
23,215,792,155.00 |
| Sub-Total of Non-Current Assets |
234,853,299,134.00 |
| Total Assets |
315,363,969,494.00 |
| Short-Term Loans |
24,612,167,832.00 |
| Trading Financial liabilities |
1,414,210,726.00 |
| Notes Payable |
1,269,370,272.00 |
| Accounts Payable |
11,896,011,424.00 |
| Accounts Received In Advance |
87,887,646.00 |
| Employee Compensation Payable |
1,497,427,584.00 |
| Taxes Payable |
3,407,251,463.00 |
| Interest Payable |
-- |
| Dividend Payable |
296,682,885.00 |
| Other payables |
10,510,346,161.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,993,768,561.00 |
| Other Current Liabilities |
2,528,636,225.00 |
| Sub-Total of Current Liabilities |
73,744,085,680.00 |
| Long-term Loans |
69,698,134,982.00 |
| Bonds Payable |
22,799,218,470.00 |
| Long-Term Accounts Payable |
3,255,551,381.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,548,437,527.00 |
| Deferred Income Tax Liabilities |
7,455,019,383.00 |
| Other Non-Current Liabilities |
2,047,574,164.00 |
| Sub-Total of Non-Current Liabilities |
110,779,143,878.00 |
| Total Liabilities |
184,523,229,558.00 |
| Paid-In Capital(Or Share Stock) |
26,328,172,240.00 |
| Capital Surplus |
25,572,169,693.00 |
| Surplus Reserve |
1,367,003,719.00 |
| LESS:Treasury Stock |
483,260,709.00 |
| Undistributed Profits |
60,199,728,071.00 |
| Minority Stockholder's Interest |
35,048,020,569.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
95,792,719,367.00 |
| Owner's Equity（Stockholder's Equity） |
130,840,739,936.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
315,363,969,494.00 |
